Ignite Creation Date:
2025-12-24 @ 3:35 PM
Ignite Modification Date:
2026-02-24 @ 3:15 PM
Study NCT ID:
NCT00665392
Status:
COMPLETED
Last Update Posted:
2025-08-01
First Post:
2008-04-22
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Cetuximab and Combination Chemotherapy in Patients With Stage III-IV Resectable Oropharynx Cancer
Sponsor:
GERCOR - Multidisciplinary Oncology Cooperative Group
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CDR0000593027
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None